Delivered Fiscal 2026 Net Sales of $4.6B, Up 7% Compared to the Prior Year Delivered Fiscal 2026 Diluted EPS of $17.05, Up 36% Compared to the Prior Year; Adjusted Diluted EPS of $19.90, Up 11% ...
54m
Everlywell Brings Clairity’s FDA-Authorized AI Breast Cancer Risk Assessment to Women Nationwide
This Breast Cancer Awareness Month, women across the U.S. can now access FDA-authorized, AI-driven assessment of future breast cancer risk Everlywell, the leader in digital health, diagnostics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results